TITLE

Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors

PUB. DATE
January 2007
SOURCE
ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a research study regarding the effectiveness of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers in reducing new-onset diabetes mellitus. The study was conducted by researcher K.L. McCall and colleagues, and was published in the journal "Pharmacotherapy." According to the study, ACE inhibitors reduce new-onset diabetes mellitus in patients with hypertension and cardiovascular risk factors.
ACCESSION #
23847341

 

Related Articles

  • ACE Inhibitors Show Damage To Kidneys From Type 1 Diabetes.  // RN;Jun2001, Vol. 64 Issue 6, p18 

    Discusses research on the effectiveness of taking angiotensin converting enzyme inhibitors to reduce the progression to macroalbuminuria and to increase the diabetic's chances of regression. Findings of the study.

  • In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events. Dans, Antonio L.; Koon Teo; Gao, Peggy; Jyh-Hong Chen; Kim Jae-Hyung; Yusoff, Khalid; Chaitraphan, Suphachai; Zhu, Jun; Liu Lisheng; Yusuf, Salim // PLoS Clinical Trials;Dec2010, Vol. 7 Issue 12, Special section p1 

    Background and Objectives: Results of the recently published ONTARGET study (The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial) showed that telmisartan (80 mg/day) was non-inferior to ramipril (10 mg/ day) in reducing cardiovascular events. Clinicians in Asia...

  • Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Chan, J.C.N.; Cockram, C.S.; Nicholls, M.G.; Cheung, C.K.; Swaminathan, R. // BMJ: British Medical Journal (International Edition);10/24/92, Vol. 305 Issue 6860, p981 

    Compares the effectiveness of enalapril and nifedipine in hypertensive patients with non-insulin dependent diabetes in Hong Kong, China. Safety of enalapril and nifedipine treatment; Description of angiotensin converting enzyme inhibitor enalapril; Characteristics of calcium channel nifedipine.

  • EFFICACY OF STATINS AND FIBRATES IN ALTERING THE LIPID PROFILE IN HYPERTENSIVE PATIENTS. SHAH, MADIHA; WAGAN, MAHBOOB AHMED; SHAH, SHAHEEN; BHURGRI, ALI NAWAZ // Medical Channel;Jul-Sep2012, Vol. 18 Issue 3, p74 

    Lipid lowering drugs have become most powerful Pharmacological strategies in treatment of cardiovascular diseases. In our study of 100 patients having an age range from 35 to 65 years were enrolled. The antihypertensive used were Angiotensin Converting Enzym Inhibitors (Lisinopril 10mg / day) &...

  • Quinapril ACE-inhibition effects on adrenergic parameters moderate essential hypertension. PRATS, MARTÍ VALLÈS; SERRA, MARGARIDA MATAS; ARTERO, JOSEP BRONSOMS; BENITO, GERARD MATÈ; ESCUDER, PERE TORGUET; NICOLAS, JOAN M. MAURI // Kidney International Supplement;Jun1996, Issue 55, pS-104 

    The effects of inhibition of the renin-angiotensin system with quinapril on adrenergic transmission were determined in 18 patients with moderate essential hypertension. Plasmatic renin activity, catecolamines, and aldosterone as well as vascular reactivity after norepinephrine and angiotensin II...

  • Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information. Powers, Benjamin; Coeytaux, Remy; Dolor, Rowena; Hasselblad, Vic; Patel, Uptal; Yancy, William; Gray, Rebecca; Irvine, R.; Kendrick, Amy; Sanders, Gillian // JGIM: Journal of General Internal Medicine;Jun2012, Vol. 27 Issue 6, p716 

    OBJECTIVES: A 2007 systematic review compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in patients with hypertension. Direct renin inhibitors (DRIs) have since been introduced, and significant new research has been published. We sought to update...

  • Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK 421): evidence for role of renin system in normotensive subjects. MacGregor, Graham A.; Markandu, Nirmala D.; Bayliss, John; Roulston, Joe E.; Squires, Marilyn; Morton, James J. // British Medical Journal (Clinical Research Edition);8/8/1981, Vol. 283 Issue 6288, p401 

    Examines the effects of non-sulfhydryl containing angiotensin-converting enzyme inhibitor on patients with high blood pressure. Role of the renin system in blood pressure; Correlation between the fall of blood pressure and the mechanism of the sulfhydryl group; Influence of captopril on...

  • ACE inhibitors improve stamina and quality of life. Dinsdale, Paul // Nursing Older People;Nov2007, Vol. 19 Issue 9, p5 

    The article discusses a medical research on the effects of regular doses of commonly-prescribed drugs for older people. The research found that giving ACE inhibitors, used in treatment of hypertension and congestive heart failure, can improve exercise capacity and physical function in the over...

  • Ramipril did not reduce incident diabetes in patients with impaired glycemic control. Gandhi, Gunjan Y.; Isley, William L. // ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p10 

    The article discusses a research study regarding the effectiveness of ramipril in reducing the risk for diabetes in patients with impaired glycemic control. The study was conducted by researcher J. Bosch and colleagues. Ramipril did not reduce diabetes in patients with impaired glucose...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics